Excerpts from article By Dr. Mercola.

Per Dr. Nass, there are only three vaccines in existence using an approved squalene adjuvant. None of the three are approved for use in the U.S.

According to Kathleen Sebelius, Secretary of the U.S. Department of Health and Human Services, your children should be the first target for mass swine flu vaccinations when school starts this fall.[i]

This is a ridiculous assumption for many reasons, not to mention extremely high risk.

In Australia, where the winter season has begun, Federal Health Minister Nicola Roxon is reassuring parents the swine flu is no more dangerous than regular seasonal flu. “Most people, including children, will experience very mild symptoms and recover without any medical intervention,” she said.[ii]

Read the complete article by Dr. Mercola:
Squalene The Swine Flu Vaccine’s Dirty Little Secret Exposed

Will There Be Immune Adjuvants in Swine Flu Vaccines?

The U.S. government has contracts with several drug companies to develop and produce swine flu vaccines. At least two of those companies, Novartis and GlaxoSmithKline, are using an adjuvant in their H1N1 vaccines.

The adjuvant? Squalene.

According to Meryl Nass, M.D., an authority on the anthrax vaccine,

“A novel feature of the two H1N1 vaccines being developed by companies Novartis and GlaxoSmithKline is the addition of squalene-containing adjuvants to boost immunogenicity and dramatically reduce the amount of viral antigen needed. This translates to much faster production of desired vaccine quantities.”[v]

Novartis’s proprietary squalene adjuvant for their H1N1 vaccine is MF59. Glaxo’s is ASO3. MF59 has yet to be approved by the FDA for use in any U.S. vaccine, despite its history of use in other countries.

Per Dr. Nass, there are only three vaccines in existence using an approved squalene adjuvant. None of the three are approved for use in the U.S.